Answers are grounded in this paper and cite their sources.
Purpose To synthesise evidence on factors influencing access to and uptake of systemic anti-cancer treatment (SACT) for people with mesothelioma, an incurable cancer, with a focus on inequities in treatment pathways and decision-making within supportive oncology care. Methods An integrative systematic review with narrative synthesis (PROSPERO: 603309) was conducted. APA PsycInfo, ASSIA, CINAHL, Cochrane Library, PubMed Central, Scopus and Web of Science were searched for English-language publications between 1 January 2008 and 18 October 2024. Eligible studies included empirical research and reproducible reviews reporting factors affecting access to or receipt of SACT among individuals with mesothelioma. Results The search yielded 716 records, of which 18 met inclusion criteria. Four interrelated themes were identified: (1) demographic characteristics; (2) information provision and decision-making; (3) clinical and disease-related factors; and (4) healthcare system and structural factors. An overarching theme of intersectionality demonstrated how social, clinical and organisational influences interact to shape treatment access and decision-making. Conclusion Access to and uptake of SACT in mesothelioma is shaped by complex, interacting patient- and system-level factors, resulting in persistent inequities in treatment pathways. As SACT is typically delivered with palliative intent in this population, these findings highlight its role within supportive oncology care and the importance of equitable access, shared decision-making and consistent information provision across services.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: